Monthly Archives: April 2024

• 

New cancer vaccine in development

By Sharon Deveson Kell|2024-05-22T07:52:40+00:0026 Apr 2024|Drug treatments|

A new vaccine is being heralded as a 'game changer’ [...]

Read More

Comments Off on New cancer vaccine in development

• 

Sick pay – cancer patients are counting the cost

By Sharon Deveson Kell|2024-04-23T14:28:33+00:0023 Apr 2024|Patient advocacy|

Statutory Sick Pay: New briefing lifts the lid on the [...]

Read More

Comments Off on Sick pay – cancer patients are counting the cost

• 

Lenvatinib plus everolimus for patients with metastatic kidney cancer

By Sharon Deveson Kell|2024-04-22T14:43:56+00:0022 Apr 2024|Uncategorized|

The treatment of heavily pretreated patients with metastatic kidney cancer [...]

Read More

Comments Off on Lenvatinib plus everolimus for patients with metastatic kidney cancer

• 

Adjuvant pembrolizumab prolongs overall survival for kidney cancer patients

By Sharon Deveson Kell|2024-04-22T14:40:54+00:0022 Apr 2024|Drug treatments|

Surgery (partial or radical nephrectomy) is the standard of care [...]

Read More

Comments Off on Adjuvant pembrolizumab prolongs overall survival for kidney cancer patients

• 

Cancer52 manifesto launch

By Sharon Deveson Kell|2024-04-22T13:24:55+00:0017 Apr 2024|Patient advocacy|

Yesterday (16 April 2024) Cancer52, an alliance of over 100 [...]

Read More

Comments Off on Cancer52 manifesto launch

• 

Immunotherapy combinations versus TKIs for papillary renal cell carcinoma

By Sharon Deveson Kell|2024-04-12T07:29:29+00:0012 Apr 2024|Drug treatments|

Papillary renal cell carcinoma (pRCC) is the most common subtype [...]

Read More

Comments Off on Immunotherapy combinations versus TKIs for papillary renal cell carcinoma

• 

CAR T cell immunotherapy shows promise for patients with kidney cancer

By Sharon Deveson Kell|2024-04-10T07:50:35+00:009 Apr 2024|Drug treatments|

Chimeric antigen receptor (CAR) T cell therapy is a type [...]

Read More

Comments Off on CAR T cell immunotherapy shows promise for patients with kidney cancer

• 

Real world data on the use of cabozantinib plus immunotherapy in the second line

By Sharon Deveson Kell|2024-04-09T08:58:22+00:009 Apr 2024|Drug treatments|

A recent study looked at the use of a combination [...]

Read More

Comments Off on Real world data on the use of cabozantinib plus immunotherapy in the second line